The molecular signature of calcineurin inhibitor (CNI) toxicity: Death to the graft!

被引：0
|
作者：
Mannon, RB
Hoffmann, S
Cheng, O
Kampen, R
Kleiner, D
Becker, B
Kirk, AD
机构：
[1] NIDDK, Transplantat Branch, NIH, Bethesda, MD USA
[2] NCI, NIH, Bethesda, MD 20892 USA
[3] Univ Wisconsin, Madison, WI USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
669
引用
收藏
页码：327 / 327
页数：1
相关论文
共 50 条
  • [31] Calcineurin inhibitor (CNI) withdrawal in adult liver transplant recipients: An analysis of long term efficacy
    Thompson, Julie A.
    Radosevich, David M.
    Humar, Abhi
    Lake, John R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 544 - 544
  • [32] Association of Treatment with Sirolimus (SIR) and Calcineurin Inhibitor (CNI) for Prevention or Treatment of Graft-Vs-Host Disease (GVHD) with Transplant Associated Microangiopathy (TAM)
    Rosenthal, Joseph
    Bolotin, Ellen
    Pawlowska, Anna
    Oliver, Cheryl
    Maroongroge, Sean
    Forman, Stephen
    [J]. BLOOD, 2008, 112 (11) : 773 - 774
  • [33] CONVERSION TO A SIROLIMIS-BASED CALCINEURIN INHIBITOR (CNI) FREE IMMUNOSUPPRESSION FOR NEUROTOXICITY IN LIVER TRANSPLANTATION
    McKenna, Greg J.
    Sanchez, Edmund Q.
    Chinnakotla, Srinath
    Randall, Henry B.
    Ruiz, Richard
    Onaca, Nicholas
    Goldstein, Robert M.
    Levy, Marlon F.
    Klintmalm, Goran B.
    [J]. LIVER TRANSPLANTATION, 2009, 15 (07) : S78 - S78
  • [34] GENETIC VARIATION IS ASSOCIATED WITH CALCINEURIN INHIBITOR (CNI) RELATED NEPHROTOXICITY: RESULTS FROM A MULTICENTER CONSORTIUM
    Yee, S.
    Nguyen, N. A.
    Brown, C.
    Cropp, C. D.
    Singh, D.
    Tahara, H.
    Choi, J.
    Castro, R. A.
    Huang, Y.
    Brett, C. M.
    Giacomini, K. M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S47 - S47
  • [35] Calcineurin Inhibitor (CNI) Delay with ATG Induction: Teaching an Old Dog, New Tricks.
    Aliabadi, A.
    Goekler, J.
    Salameh, O.
    Haberl, T.
    Steinlechner, B.
    Opfermann, P.
    Kaider, A.
    Uyanik-Uenal, K.
    Laufer, G.
    Zuckermann, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 550 - 550
  • [36] BEHAVIOURAL PROBLEMS AFTER PEDIATRIC LIVER TRANSPLANTATION (PLTX) - RELATED TO CALCINEURIN INHIBITOR (CNI) THERAPY?
    Schulz-Juergensen, S.
    Becker, F.
    Otto-Morris, C.
    Kohl, M.
    Burdelski, M.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 11 - 11
  • [37] COMPARISON OF THE EFFICACY AND SAFETY OF CALCINEURIN INHIBITOR CONVERSION TO mTOR INHIBITOR AND CNI MINIMIZATION IN KIDNEY TRANSPLANTS WITH CHRONIC ALLOGRAFT NEPHROPATHY
    Rojsanga, Piyarat
    Vongwiwatana, Attapong
    Premasathian, Nalinee
    Vasuvattakul, Somkiat
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 300 - 300
  • [38] A molecular signature for delayed graft function
    McGuinness, Dagmara
    Mohammed, Suhaib
    Monaghan, Laura
    Wilson, Paul A.
    Kingsmore, David B.
    Shapter, Oliver
    Stevenson, Karen S.
    Coley, Shana M.
    Devey, Luke
    Kirkpatrick, Robert B.
    Shiels, Paul G.
    [J]. AGING CELL, 2018, 17 (05)
  • [39] Progression of liver fibrosis in HCV-positive liver transplant recipients randomized to everolimus with reduced calcineurin inhibitor (CNI) therapy or a standard CNI regimen
    Saliba, Faouzi
    Nevens, Frederik
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 (03) : 373 - 374
  • [40] CALCINEURIN INHIBITOR (CNI) WITHDRAWAL IN ADULT LIVER TRANSPLANT RECIPIENTS: AN ANALYSIS OF LONG TERM EFFICACY.
    Thompson, Julie A.
    Radosevich, David M.
    Humar, Abhi
    Lake, John R.
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S107 - S107
12345